Skip to main content
SpringerLink
Log in

Lokal fortgeschrittenes Harnblasenkarzinom

Organ erhaltende Behandlung

Locally advanced bladder cancer

Organ-preserving treatment

  • Weiterbildung · Zertifizierte Fortbildung
  • Published:
Der Onkologe Aims and scope

Zusammenfassung

Eine organ- und funktionserhaltende Behandlung hat sich in den letzten 2 Jahrzehnten bei vielen Tumorentitäten durchgesetzt, z. B. beim Mammakarzinom, Larynxkarzinomen und anderen Plattenepithelkarzinomen im Kopf-Hals-Bereich oder gastrointestinalen Tumoren. In diesen Behandlungskonzepten spielt die Radio(chemo)therapie eine entscheidende Rolle. Ein auf Organerhaltung ausgerichtetes Behandlungskonzept ist auch beim muskelinvasiven Harnblasenkarzinom als Alternative zur radikalen Zystektomie onkologisch sinnvoll und in der Effektivität durch klinische Daten gut belegt.

Abstract

Treatment that preserves the organ and its normal function has gained acceptance for many tumor entities in the last 2 decades, e.g., in breast cancer, larynx cancer and other squamous cell carcinomas in the head and neck regions, or gastrointestinal tumors. Radio(chemo)therapy plays a major role in these therapy concepts. A treatment concept aimed at preserving the organ also makes sense from the oncological perspective in cases of muscle-invading bladder cancer as a alternative to radical cystectomy, and its efficacy has been well documented by clinical data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Advanced Bladder Cancer Meta-Analysis Collaboration Group (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361: 1927–1934

    Article  Google Scholar 

  2. Coppin CM, Gospodarowisz MK, James K et al. (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14: 2901–2907

    Google Scholar 

  3. Dunst J, Rödel C (2002) Harnblasenkarzinom. In: Sack H, Bamberg M (Hrsg) Strahlentherapie—Radiologische Onkologie. Springer, Berlin Heidelberg New York

  4. Dunst J, Rödel C, Schrott KM, Zietman A, Sauer R, Shipley WU (2001) Bladder preservation in muscle-invasive bladder cancer by transurethral surgery and radiochemotherapy. Semin Surg Oncol 20: 24–32

    Article  Google Scholar 

  5. Hayter CR, Paszat LF, Groome PA et al. (1999) A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 45: 1239–1245

    Article  Google Scholar 

  6. Housset M, Maulard C, Chretien YC et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150–2157

    Google Scholar 

  7. Kachnic LA, Kaufmann DS, Griffin PP, Heney NM, Alfthausen AF, Zietmann AL, Shipley WU (1997) Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15: 1022–1029

    Google Scholar 

  8. Moore MJ, O’Sullivan B, Tannock I (1988) How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 6: 1736–1745

    Google Scholar 

  9. Rödel C, Dunst J, Kühn R, Schrott KM, Sauer R (2002) Organ-sparing treatment of advanced bladder cancer. J Clin Oncol 20: 3061–3071

    Article  Google Scholar 

  10. Shipley WU, Zietman AL, Kaufman DS, Althausen AF, Heney NM (1997) Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation. Int J Radiat Oncol Biol Phys 39: 937–943

    Article  Google Scholar 

  11. Stein JP, Lieskovsky G, Cote R et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666–675

    CAS  PubMed  Google Scholar 

  12. Tester W, Porter A, Asbell S et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 25: 783–790

    Google Scholar 

  13. Tester W, Porter A, Heaney J et al. (1996) Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer. J Clin Oncol 14: 119–126

    Google Scholar 

  14. Zietman AL, Shipley WU, Kaufman DS (1993) The combination of cis-platinum based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. Int J Radiat Oncol Biol Phys 27: 161–170

    Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

  1. Universitätsklinik und Poliklinik für Strahlentherapie, Martin-Luther-Universität Halle-Wittenberg

    J. Dunst

  2. Klinik für Strahlentherapie, Friedrich-Alexander-Universität , Erlangen

    C. Rödel

  3. Universitätsklinik und Poliklinik für Strahlentherapie, Martin-Luther-Universität Halle-Wittenberg, Voßstraße 1, Dryanderstraße 4–7, 06110 , Halle, Saale

    J. Dunst

Authors
  1. J. Dunst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Rödel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Dunst.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunst, J., Rödel, C. Lokal fortgeschrittenes Harnblasenkarzinom. Onkologe 11, 107–116 (2005). https://doi.org/10.1007/s00761-004-0821-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-004-0821-1

Schlüsselwörter

Keywords

Search

Navigation